Gene Symbol | Pearson Correlation Coefficient |
---|---|
AP3S1 | 0.967 |
MORF4L1 | 0.966 |
BEX4 | 0.964 |
PEBP1 | 0.964 |
NGRN | 0.957 |
BRK1 | 0.956 |
EIF4A2 | 0.955 |
MRFAP1L1 | 0.955 |
PPIA | 0.955 |
EMC4 | 0.954 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.869 |
OR4F29 | -0.857 |
KCNJ15 | -0.267 |
FOLR3 | -0.258 |
RUNX3 | -0.25 |
TFPI2 | -0.246 |
CXCR2 | -0.24 |
SIX1 | -0.237 |
MTRNR2L6 | -0.236 |
MAGEA12 | -0.233 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB11093 | Calcium Citrate | Small Molecule | 813-94-5 | Approved | Target |
DB11348 | Calcium Phosphate | Small Molecule | 10103-46-5 | Approved | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of CALM2 mRNA" | 21346803 |
C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of CALM2 mRNA] | 28655636 |
C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of CALM2 mRNA] | 28655636 |
C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]" | 11179685 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of CALM2 gene | 27153756 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CALM2 mRNA | 16483693 |
D000661 | Amphetamine | Amphetamine affects the expression of CALM2 mRNA | 10854758 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CALM2 mRNA | 25339124 |
C015001 | arsenite | arsenite results in increased methylation of CALM2 promoter | 23974009 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CALM2 mRNA | 22228805 |
D004958 | Estradiol | "3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]" | 11179685 |
D004958 | Estradiol | Estradiol results in decreased expression of CALM2 mRNA | 11179685 |
D004958 | Estradiol | Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA] | 11179685 |
D004958 | Estradiol | [bisphenol A co-treated with Estradiol] results in increased expression of CALM2 mRNA | 26496021 |
C006780 | bisphenol A | [bisphenol A co-treated with Estradiol] results in increased expression of CALM2 mRNA | 26496021 |
C006780 | bisphenol A | bisphenol A results in increased methylation of CALM2 gene | 28505145 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of CALM2 mRNA | 18958704 |
C515564 | bromovanin | bromovanin results in increased expression of CALM2 protein | 21419150 |
D002065 | Buspirone | Buspirone results in decreased expression of CALM2 mRNA | 24136188 |
D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of CALM2 mRNA | 16122865 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CALM2 mRNA | 25035189 |
D019256 | Cadmium Chloride | Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of CALM2 mRNA] | 25035189 |
D002186 | Cannabinoids | Cannabinoids results in decreased expression of CALM2 mRNA | 17205118 |
C026690 | cerous chloride | cerous chloride results in increased expression of CALM2 mRNA | 23573234 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of CALM2 mRNA | 23650126 |
C100187 | chloropicrin | chloropicrin results in increased expression of CALM2 mRNA | 26352163 |
D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALM2 mRNA | 17602206 |
D003024 | Clozapine | Clozapine results in increased expression of CALM2 mRNA | 19289156 |
D003042 | Cocaine | Cocaine results in decreased expression of CALM2 mRNA | 17205118 |
D003300 | Copper | Copper results in decreased expression of CALM2 mRNA | 25646894 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CALM2 mRNA | 19549813 |
D003471 | Cuprizone | Cuprizone results in decreased expression of CALM2 mRNA | 26577399 |
C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CALM2 mRNA | 17654400 |
C009160 | cyclonite | cyclonite affects the expression of CALM2 mRNA | 19417177 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of CALM2 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CALM2 mRNA | 27392435 |
C000944 | dicrotophos | dicrotophos results in decreased expression of CALM2 mRNA | 28302478 |
D004026 | Dieldrin | Dieldrin affects the expression of CALM2 mRNA | 22546817 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CALM2 mRNA | 18042831 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALM2 mRNA | 17602206 |
D004237 | Diuron | Diuron results in increased expression of CALM2 mRNA | 21551480 |
D000431 | Ethanol | Ethanol results in decreased expression of CALM2 mRNA | 20655511 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CALM2 protein | 20381887 |
C056933 | fumonisin B1 | fumonisin B1 results in increased expression of CALM2 mRNA | 16221962 |
D005839 | Gentamicins | Gentamicins results in increased expression of CALM2 mRNA | 22061828 |
D005947 | Glucose | CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | 21124846 |
D005947 | Glucose | [INS protein co-treated with Glucose] results in decreased expression of CALM2 mRNA | 22634610 |
D006220 | Haloperidol | Haloperidol results in increased expression of CALM2 mRNA | 19289156 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CALM2 mRNA | 20044591 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CALM2 mRNA | 25613284 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of CALM2 mRNA | 27392435 |
C544151 | jinfukang | jinfukang results in decreased expression of CALM2 mRNA | 27392435 |
C410337 | K 7174 | K 7174 results in decreased expression of CALM2 mRNA | 24086573 |
D008344 | Maneb | [Paraquat co-treated with Maneb] results in increased expression of CALM2 mRNA | 18386188 |
D008727 | Methotrexate | Methotrexate results in increased expression of CALM2 mRNA | 21678067 |
D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA] | 27264040 |
C568376 | MT19c compound | MT19c compound results in increased expression of CALM2 mRNA | 21781307 |
C051752 | nefazodone | nefazodone results in decreased expression of CALM2 mRNA | 24136188 |
C022838 | nickel chloride | nickel chloride affects the expression of CALM2 mRNA | 22546817 |
C012655 | nimesulide | nimesulide results in decreased expression of CALM2 mRNA | 24136188 |
D005996 | Nitroglycerin | Nitroglycerin results in increased expression of CALM2 mRNA | 12102619 |
D019319 | Okadaic Acid | Okadaic Acid results in decreased expression of CALM2 mRNA | 23561263 |
D010100 | Oxygen | CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] | 21124846 |
D000073878 | Palm Oil | Palm Oil results in increased expression of CALM2 mRNA | 18042831 |
D010269 | Paraquat | [Paraquat co-treated with Maneb] results in increased expression of CALM2 mRNA | 18386188 |
D052638 | Particulate Matter | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of CALM2 mRNA] | 28655636 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of CALM2 mRNA | 28412507|2865563 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of CALM2 mRNA | 19756518 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CALM2 mRNA | 19756518 |
D010622 | Phencyclidine | Phencyclidine results in decreased expression of CALM2 mRNA | 17205118 |
D010634 | Phenobarbital | Phenobarbital affects the expression of CALM2 mRNA | 19159669 |
D010672 | Phenytoin | Phenytoin results in decreased expression of CALM2 mRNA | 14741686 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of CALM2 mRNA | 23557933 |
D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA] | 27264040 |
D011374 | Progesterone | Progesterone results in decreased expression of CALM2 mRNA | 27264040 |
D018967 | Risperidone | Risperidone results in increased expression of CALM2 mRNA | 19289156 |
D012643 | Selenium | Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of CALM2 mRNA] | 25035189 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CALM2 mRNA | 21340527 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA] | 11179685 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CALM2 mRNA | 21570461 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CALM2 mRNA | 25613284 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CALM2 mRNA" | 19682533 |
D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of CALM2 gene | 27618143 |
C012589 | trichostatin A | trichostatin A results in increased expression of CALM2 mRNA | 15901671 |
D014415 | Tunicamycin | Tunicamycin results in decreased expression of CALM2 mRNA | 22378314 |
D014501 | Uranium | Uranium affects the expression of CALM2 mRNA | 15672453 |
D017974 | Uranium Compounds | Uranium Compounds results in decreased expression of CALM2 mRNA | 19654044 |
C005460 | uranyl acetate | uranyl acetate affects the expression of CALM2 mRNA | 15672453 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of CALM2 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CALM2 mRNA | 19101580 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CALM2 mRNA | 15901671 |
D001335 | Vehicle Emissions | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of CALM2 mRNA] | 28655636 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of CALM2 mRNA | 28655636 |
D014750 | Vincristine | Vincristine results in decreased expression of CALM2 mRNA | 23649840 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005509 | calcium ion binding | - | IDA | 7607248 8631777 11807546 23040497 26164367 26969752 27516456 |
GO:0005515 | protein binding | - | IPI | 3111527 10692436 15140941 16760425 19855925 21299499 |
GO:0008179 | adenylate cyclase binding | - | IPI | 11807546 |
GO:0019855 | calcium channel inhibitor activity | - | IDA | 26969752 |
GO:0019901 | protein kinase binding | - | IPI | 20668654 |
GO:0019904 | protein domain specific binding | - | IPI | 11984006 |
GO:0031432 | titin binding | - | IPI | 7607248 |
GO:0031997 | N-terminal myristoylation domain binding | - | IPI | 15632291 |
GO:0043539 | protein serine/threonine kinase activator activity | - | TAS | 20668654 |
GO:0044325 | ion channel binding | - | IPI | 21167176 23040497 |
GO:0072542 | protein phosphatase activator activity | - | IDA | 8631777 |
GO:0097718 | disordered domain specific binding | - | IPI | 19855925 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0002027 | regulation of heart rate | - | IMP | 23040497 |
GO:0005513 | detection of calcium ion | - | IMP | 23040497 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | 10899953 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | - | TAS | 20668654 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | - | TAS | 20668654 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | - | IDA | 20226167 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | - | IC | - |
GO:0021762 | substantia nigra development | - | HEP | 22926577 |
GO:0031954 | positive regulation of protein autophosphorylation | - | TAS | 20668654 |
GO:0032465 | regulation of cytokinesis | - | IMP | 16760425 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | - | IDA | 8631777 |
GO:0035307 | positive regulation of protein dephosphorylation | - | IDA | 8631777 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | - | IDA | 8631777 |
GO:0051592 | response to calcium ion | - | IDA | 7607248 |
GO:0055117 | regulation of cardiac muscle contraction | - | IMP | 23040497 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | - | IDA | 26164367 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | - | IDA | 20226167 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | - | TAS | 20668654 |
GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction | - | IC | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000922 | spindle pole | - | IDA | 16760425 |
GO:0005634 | nucleus | - | HDA | 21630459 |
GO:0005737 | cytoplasm | - | IDA | 27165696 |
GO:0005737 | cytoplasm | - | TAS | 10899953 |
GO:0005813 | centrosome | - | IDA | 16760425 |
GO:0005876 | spindle microtubule | - | IDA | 16760425 |
GO:0005886 | plasma membrane | - | TAS | 10899953 |
GO:0030017 | sarcomere | - | IDA | 20226167 |
GO:0031982 | vesicle | - | HDA | 19190083 |
GO:0032991 | protein-containing complex | - | IDA | 19855925 |
GO:0034704 | calcium channel complex | - | IDA | 23040497 |
GO:1902494 | catalytic complex | - | IDA | 11807546 |
KEGG ID | KEGG Term |
---|---|
hsa04020 | Calcium signaling pathway |
hsa04070 | Phosphatidylinositol signaling system |
hsa04114 | Oocyte meiosis |
hsa04270 | Vascular smooth muscle contraction |
hsa04720 | Long-term potentiation |
hsa04722 | Neurotrophin signaling pathway |
hsa04740 | Olfactory transduction |
hsa04744 | Phototransduction |
hsa04910 | Insulin signaling pathway |
hsa04912 | GnRH signaling pathway |
hsa04916 | Melanogenesis |
hsa04970 | Salivary secretion |
hsa04971 | Gastric acid secretion |
hsa05010 | Alzheimer's disease |
hsa05214 | Glioma |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109582 | Hemostasis | TAS |
R-HSA-111885 | Opioid Signalling | TAS |
R-HSA-111885 | Opioid Signalling | IEA |
R-HSA-111931 | PKA-mediated phosphorylation of CREB | TAS |
R-HSA-111932 | CaMK IV-mediated phosphorylation of CREB | TAS |
R-HSA-111932 | CaMK IV-mediated phosphorylation of CREB | IEA |
R-HSA-111933 | Calmodulin induced events | TAS |
R-HSA-111933 | Calmodulin induced events | IEA |
R-HSA-111957 | Cam-PDE 1 activation | TAS |
R-HSA-111996 | Ca-dependent events | TAS |
R-HSA-111996 | Ca-dependent events | IEA |
R-HSA-111997 | CaM pathway | TAS |
R-HSA-111997 | CaM pathway | IEA |
R-HSA-112040 | G-protein mediated events | TAS |
R-HSA-112040 | G-protein mediated events | IEA |
R-HSA-112043 | PLC beta mediated events | TAS |
R-HSA-112043 | PLC beta mediated events | IEA |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | TAS |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | IEA |
R-HSA-112315 | Transmission across Chemical Synapses | TAS |
R-HSA-112315 | Transmission across Chemical Synapses | IEA |
R-HSA-112316 | Neuronal System | TAS |
R-HSA-112316 | Neuronal System | IEA |
R-HSA-114608 | Platelet degranulation | TAS |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | TAS |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | IEA |
R-HSA-1280218 | Adaptive Immune System | TAS |
R-HSA-1280218 | Adaptive Immune System | IEA |
R-HSA-1430728 | Metabolism | TAS |
R-HSA-1430728 | Metabolism | IEA |
R-HSA-1445148 | Translocation of GLUT4 to the plasma membrane | IEA |
R-HSA-1474151 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | TAS |
R-HSA-1483249 | Inositol phosphate metabolism | TAS |
R-HSA-1489509 | DAG and IP3 signaling | TAS |
R-HSA-1489509 | DAG and IP3 signaling | IEA |
R-HSA-1592230 | Mitochondrial biogenesis | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-162582 | Signal Transduction | IEA |
R-HSA-163615 | PKA activation | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168249 | Innate Immune System | IEA |
R-HSA-168256 | Immune System | TAS |
R-HSA-168256 | Immune System | IEA |
R-HSA-180024 | DARPP-32 events | IEA |
R-HSA-1852241 | Organelle biogenesis and maintenance | IEA |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | TAS |
R-HSA-194138 | Signaling by VEGF | IEA |
R-HSA-194138 | Signaling by VEGF | TAS |
R-HSA-194315 | Signaling by Rho GTPases | TAS |
R-HSA-194315 | Signaling by Rho GTPases | IEA |
R-HSA-195258 | RHO GTPase Effectors | TAS |
R-HSA-195258 | RHO GTPase Effectors | IEA |
R-HSA-195721 | Signaling by WNT | TAS |
R-HSA-196854 | Metabolism of vitamins and cofactors | TAS |
R-HSA-199991 | Membrane Trafficking | IEA |
R-HSA-202131 | Metabolism of nitric oxide | TAS |
R-HSA-2025928 | Calcineurin activates NFAT | TAS |
R-HSA-2025928 | Calcineurin activates NFAT | IEA |
R-HSA-203615 | eNOS activation | TAS |
R-HSA-203765 | eNOS activation and regulation | TAS |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | IEA |
R-HSA-2187338 | Visual phototransduction | IEA |
R-HSA-2187338 | Visual phototransduction | TAS |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | TAS |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | IEA |
R-HSA-2514856 | The phototransduction cascade | IEA |
R-HSA-2514856 | The phototransduction cascade | TAS |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | IEA |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | TAS |
R-HSA-2672351 | Stimuli-sensing channels | TAS |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | TAS |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | IEA |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-372790 | Signaling by GPCR | IEA |
R-HSA-382551 | Transport of small molecules | TAS |
R-HSA-3858494 | Beta-catenin independent WNT signaling | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-388396 | GPCR downstream signalling | IEA |
R-HSA-392499 | Metabolism of proteins | TAS |
R-HSA-397014 | Muscle contraction | TAS |
R-HSA-397014 | Muscle contraction | IEA |
R-HSA-4086398 | Ca2+ pathway | TAS |
R-HSA-418346 | Platelet homeostasis | TAS |
R-HSA-418359 | Reduction of cytosolic Ca++ levels | TAS |
R-HSA-418360 | Platelet calcium homeostasis | TAS |
R-HSA-418594 | G alpha (i) signalling events | TAS |
R-HSA-418594 | G alpha (i) signalling events | IEA |
R-HSA-425393 | Transport of inorganic cations/anions and amino acids/oligopeptides | TAS |
R-HSA-425407 | SLC-mediated transmembrane transport | TAS |
R-HSA-425561 | Sodium/Calcium exchangers | TAS |
R-HSA-438064 | Post NMDA receptor activation events | TAS |
R-HSA-438064 | Post NMDA receptor activation events | IEA |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | IEA |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | TAS |
R-HSA-442717 | CREB phosphorylation through the activation of CaMKK | TAS |
R-HSA-442717 | CREB phosphorylation through the activation of CaMKK | IEA |
R-HSA-442729 | CREB phosphorylation through the activation of CaMKII | TAS |
R-HSA-442742 | CREB phosphorylation through the activation of Ras | TAS |
R-HSA-442745 | Activation of CaMK IV | TAS |
R-HSA-442745 | Activation of CaMK IV | IEA |
R-HSA-442755 | Activation of NMDA receptor and postsynaptic events | TAS |
R-HSA-442755 | Activation of NMDA receptor and postsynaptic events | IEA |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | TAS |
R-HSA-445355 | Smooth Muscle Contraction | IEA |
R-HSA-445355 | Smooth Muscle Contraction | TAS |
R-HSA-451306 | Ionotropic activity of kainate receptors | TAS |
R-HSA-451308 | Activation of Ca-permeable Kainate Receptor | TAS |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | TAS |
R-HSA-5210891 | Uptake and function of anthrax toxins | TAS |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | TAS |
R-HSA-5218921 | VEGFR2 mediated cell proliferation | IEA |
R-HSA-5339562 | Uptake and actions of bacterial toxins | TAS |
R-HSA-5576891 | Cardiac conduction | TAS |
R-HSA-5576892 | Phase 0 - rapid depolarisation | TAS |
R-HSA-5578775 | Ion homeostasis | TAS |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | TAS |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | IEA |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | TAS |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | IEA |
R-HSA-5621481 | C-type lectin receptors (CLRs) | TAS |
R-HSA-5621481 | C-type lectin receptors (CLRs) | IEA |
R-HSA-5626467 | RHO GTPases activate IQGAPs | TAS |
R-HSA-5627123 | RHO GTPases activate PAKs | TAS |
R-HSA-5627123 | RHO GTPases activate PAKs | IEA |
R-HSA-5653656 | Vesicle-mediated transport | IEA |
R-HSA-5663205 | Infectious disease | TAS |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-597592 | Post-translational protein modification | TAS |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | TAS |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | IEA |
R-HSA-71387 | Metabolism of carbohydrates | TAS |
R-HSA-71387 | Metabolism of carbohydrates | IEA |
R-HSA-76002 | Platelet activation, signaling and aggregation | TAS |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | TAS |
R-HSA-8876725 | Protein methylation | TAS |
R-HSA-8978934 | Metabolism of cofactors | TAS |
R-HSA-8982491 | Glycogen metabolism | TAS |
R-HSA-8982491 | Glycogen metabolism | IEA |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | IEA |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | IEA |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
R-HSA-936837 | Ion transport by P-type ATPases | TAS |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | IEA |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | TAS |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | IEA |
R-HSA-983712 | Ion channel transport | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
21546767 | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. (2011) | Murea M | Am J Nephrol |